<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00076323</url>
  </required_header>
  <id_info>
    <org_study_id>WRAIR 992</org_study_id>
    <secondary_id>G6PD</secondary_id>
    <nct_id>NCT00076323</nct_id>
  </id_info>
  <brief_title>A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency</brief_title>
  <official_title>A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Walter Reed Army Institute of Research (WRAIR)</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Walter Reed Army Institute of Research (WRAIR)</source>
  <brief_summary>
    <textblock>
      This study will evaluate a new and safe testing method for identifying medicines that can
      cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are
      looking for volunteers with G6PD deficiency who would be willing to donate blood samples.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2003</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in degree of hemolysis of G6PD(-) red blood cells in treated vs untreated matched samples.</measure>
  </primary_outcome>
  <enrollment>14</enrollment>
  <condition>Glucosephosphate Dehydrogenase Deficiency</condition>
  <condition>Favism</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Primaquine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

          -  Normal clinical evaluation

          -  Willing and able to make all scheduled visits

        Exclusion:

          -  pregnant or planning pregnancy

          -  Have taken any anti-malarial medication in past month

          -  Positive blood tests for HIV and specific types of hepatitis

          -  Allergic to primaquine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shon A Remich</last_name>
    <role>Principal Investigator</role>
    <affiliation>WRAIR, Experimental Therapeutics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Walter Reed Army Institute of Research</name>
      <address>
        <city>Silver Spring</city>
        <state>Maryland</state>
        <zip>20910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.wrairclinicaltrials.com/</url>
    <description>Recruitment page for WRAIR Clinical Trials Center</description>
  </link>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2004</study_first_submitted>
  <study_first_submitted_qc>January 20, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2004</study_first_posted>
  <last_update_submitted>July 26, 2010</last_update_submitted>
  <last_update_submitted_qc>July 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2010</last_update_posted>
  <keyword>G6PD</keyword>
  <keyword>Favism</keyword>
  <keyword>G6PD Deficiency</keyword>
  <keyword>hemolysis</keyword>
  <keyword>drug reaction</keyword>
  <keyword>drug-induced hemolysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucosephosphate Dehydrogenase Deficiency</mesh_term>
    <mesh_term>Favism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Primaquine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

